We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma

This study is currently recruiting participants.
Verified September 2017 by Nabil Ahmed, Baylor College of Medicine
Sponsor:
ClinicalTrials.gov Identifier:
NCT00902044
First Posted: May 14, 2009
Last Update Posted: October 2, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborators:
Texas Children's Hospital
The Methodist Hospital System
Center for Cell and Gene Therapy, Baylor College of Medicine
Information provided by (Responsible Party):
Nabil Ahmed, Baylor College of Medicine
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2031
  Estimated Primary Completion Date: July 2018 (Final data collection date for primary outcome measure)